» Authors » Sadegh Azimzadeh Jamalkandi

Sadegh Azimzadeh Jamalkandi

Explore the profile of Sadegh Azimzadeh Jamalkandi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 480
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Ahmadi A, Ahrari S, Salimian J, Salehi Z, Karimi M, Emamvirdizadeh A, et al.
Cell Commun Signal . 2023 Nov; 21(1):314. PMID: 37919729
Background: Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar remodeling. Although the abnormalities are primarily prompted by chronic exposure...
3.
Masjedy A, Salesi M, Ahmadi A, Salimian J, Azimzadeh Jamalkandi S
Cytokine . 2023 Sep; 171:156352. PMID: 37703677
Chronic obstructive pulmonary disease (COPD) is a common chronic inflammatory disease with high morbidity and mortality rates worldwide. Cytokines, which are the main regulators of immune responses, play crucial roles...
4.
Najafi S, Azimzadeh Jamalkandi S, Najafi A, Salimian J, Ahmadi A
BMC Microbiol . 2023 Jul; 23(1):182. PMID: 37434142
Background: It has been demonstrated in the literature that a dysbiotic microbiome could have a negative impact on the host immune system and promote disease onset or exacerbation. Co-occurrence networks...
5.
Salehi Z, Nobakht Motlagh Ghoochani B, Hasani Nourian Y, Azimzadeh Jamalkandi S, Ghanei M
Allergy Asthma Clin Immunol . 2023 Jun; 19(1):49. PMID: 37264452
The effects of nicotine and cigarette smoke in many diseases, notably COVID-19 infection, are being debated more frequently. The current basic data for COVID-19 is increasing and indicating the higher...
6.
Hasani Nourian Y, Salimian J, Ahmadi A, Salehi Z, Karimi M, Emamvirdizadeh A, et al.
Biochem Biophys Rep . 2023 Mar; 34:101438. PMID: 36865738
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death among non-contagious diseases in the world. PDE inhibitors are among current medicines prescribed for COPD treatment of which,...
7.
Halabian R, Arshad V, Ahmadi A, Saeedi P, Azimzadeh Jamalkandi S, Alivand M
Cell Mol Biol Lett . 2022 Sep; 27(1):78. PMID: 36131242
No abstract available.
8.
Mostafaei S, Borna H, Emamvirdizadeh A, Arabfard M, Ahmadi A, Salimian J, et al.
COPD . 2022 Jun; 19(1):290-299. PMID: 35696265
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory disease with pulmonary and extra-pulmonary complications. Due to the disease's systemic nature, many investigations investigated the genetic alterations in various biological...
9.
Namiranian P, Sadatpour O, Azimzadeh Jamalkandi S, Ayati M, Karimi M
J Tradit Chin Med . 2022 May; 42(3):332-343. PMID: 35610002
Objective: To investigate the and studies of natural compounds and medicinal plants with anti-coronavirus activity. Methods: A systematic review was performed based on Preferred Reporting Items for Systematic Reviews and...
10.
Khoshbakht S, Mokhtari M, Moravveji S, Azimzadeh Jamalkandi S, Masoudi-Nejad A
BMC Genom Data . 2022 Jan; 23(1):6. PMID: 35031021
Background: Elucidating the dynamic topological changes across different stages of breast cancer, called stage re-wiring, could lead to identifying key latent regulatory signatures involved in cancer progression. Such dynamic regulators...